6.0% of global mortality) and 90.7 million DALYs (95% uncertainty interval, 58.9-123.3 million
Increased gastric content due to delayed gastric emptying might have a negative impact on medical procedures performed under monitored sedation, such as esophagogastroduodenoscopy (EGD) or colonoscopy
First isolated in the 1990s, it earned the name Body Protective Compound-157 for its ability to accelerate healing in the stomach and intestine
GLP1/GIP - Tirzepatide Tirzepatide is a dual GLP-1 and GIP receptor agonist that may be prescribed following a comprehensive evaluation with one of our licensed medical providers, when clinically appropriate
Cannabis and GLP-1 medications can both influence symptoms or behaviors that matter during treatment, including eating patterns, nausea, dizziness, sedation, and gastrointestinal comfort